Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.21.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Oct. 31, 2021
Oct. 31, 2020
Current assets:    
Cash and cash equivalents $ 9,298 $ 6,736
Trade receivables, net 49,034 44,343
Inventory 4,902 4,630
Income taxes receivable 275 1,602
Prepaid expenses and other current assets 4,110 2,694
Total current assets 67,619 60,005
Property, plant and equipment, net 337,771 304,254
Intangible assets, net 158,539 183,839
Goodwill 224,700 223,154
Other non-current assets 2,168 1,753
Deferred financing costs 1,868 753
Total assets 792,665 773,758
Current liabilities:    
Revolving loan 990 1,741
Term loans, current portion 0 20,888
Current portion of capital lease obligations 103 97
Accounts payable 10,706 6,587
Accrued payroll and payroll expenses 12,226 13,065
Accrued expenses and other current liabilities 23,940 18,879
Income taxes payable 274 1,055
Total current liabilities 48,239 62,312
Long term debt, net of discount for deferred financing costs 369,084 343,906
Capital lease obligations, less current portion 278 380
Deferred income taxes 70,566 68,019
Warrant liability 16,923 7,031
Total liabilities 505,090 481,648
Commitments and contingencies (see Note 13)
Zero-dividend convertible perpetual preferred stock, $0.0001 par value, 2,450,980 shares issued and outstanding as of October 31, 2021 and October 31, 2020 25,000 25,000
Stockholders' equity    
Common stock, $0.0001 par value, 500,000,000 shares authorized, 56,564,642 and 56,463,992 issued and outstanding as of October 31, 2021 and October 31, 2020, respectively 6 6
Additional paid-in capital 374,272 367,681
Treasury stock (461) (131)
Accumulated other comprehensive income (loss) 3,671 (606)
Accumulated deficit (114,913) (99,840)
Total stockholders' equity 262,575 267,110
Total liabilities and stockholders' equity $ 792,665 $ 773,758